Tadalafil for veterans with chronic obstructive pulmonary disease-pulmonary hypertension: A multicenter, placebo-controlled randomized trial

By rosaguerrero • May 4, 2022

Maron BA, Choudhary G, Goldstein RL, Garshick E, Jankowich M, Tucker TJS, LaCerda KA, Hattler B, Dempsey EC, Sadikot RT, Shapiro S, Rounds SI, Goldstein RH. Tadalafil for veterans with chronic obstructive pulmonary disease-pulmonary hypertension: A multicenter, placebo-controlled randomized trial. Pulm Circ. 2022 Mar 14;12(1):e12043. doi: 10.1002/pul2.12043. PMID: 35506072; PMCID: PMC9053004.

Tags: Cardiology/Epi, exercise capacity, lung disease, pulmonary vascular disease, Pulmonary, Critical Care & Sleep Medicine

Predicting in-hospital mortality among patients admitted with a diagnosis of heart failure: a machine learning approach

Jawadi Z, He R, Srivastava PK, Fonarow GC, Khalil SO, Krishnan S, Eskin E, Chiang JN, Nsair A. Predicting in-hospital mortality among patients admitted with[...]

Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective Cohort

Wong ND, Fan W, Hu X, Ballantyne C, Hoodgeveen RC, Tsai MY, Browne A, Budoff MJ. Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled[...]

Toward a Universal Definition of Etiologies in Heart Failure: Categorizing Causes and Advancing Registry Science

Agarwal A, Tromp J, Almahmeed W, Angermann C, Chandramouli C, Cho H, Choi DJ, Damasceno A, Filippatos G, Fonarow GC, Harikrishnan S, Lund L, Masoudi[...]